Publication | Closed Access

Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1

OncologyMedicineCancer Cell BiologyAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyTumor BiologyCancer Growth